[Modulation of immunity in cancerous patient : an weapon with double edges?].
Nutritional support of cancer patients should ideally contribute to improve the immune defence, maintain the protein body pool and sensitize the tumour to oncologic treatments. Such a goal is not easy to achieve, because any nutritional support efficient at stimulating immune response and protein syntheses might also simultaneously stimulate the tumour growth. Contradictory observations have been reported for several nutrients contained in the nutritive solutions available on the market. This is the case for glutamine, arginine, omega-3 fatty acids and nucleotides. Their clinical use during oncologic therapies deserves further testing and analysis.
Dupertuis
Yves Marc
YM
Hôpitaux Universitaires de Genève, 1211 Genève 14.
Genton
Laurence
L
Uldry
Christiane
C
Maisonneuve
Nadine
N
Karsegard
Véronique
V
Pichard
Claude
C
D000818:Animals; D001120:Arginine / Q000008:administration & dosage; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D005973:Glutamine / Q000008:administration & dosage; D006801:Humans; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D009711:Nucleotides / Q000008:administration & dosage; D016896:Treatment Outcome
D015525:Fatty Acids, Omega-3; D009711:Nucleotides; D005973:Glutamine; D001120:Arginine